Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases

Yukihiro Sanada; Yasunaru Sakuma; Yasuharu Onishi; Noriki Okada; Naoya Yamada; Yuta Hirata; Go Miyahara; Takumi Katano; Toshio Horiuchi; Takahiko Omameuda; Alan Kawarai Lefor; Naohiro Sata

doi:10.12659/AOT.932994

01 October 2021 : Original article

Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases

Yukihiro Sanada^1ABCDEF*, Yasunaru Sakuma^1DF, Yasuharu Onishi^1B, Noriki Okada^1B, Naoya Yamada^1B, Yuta Hirata^1B, Go Miyahara^1B, Takumi Katano^1B, Toshio Horiuchi^1B, Takahiko Omameuda^1B, Alan Kawarai Lefor

^1DF, Naohiro Sata^1DF

DOI: 10.12659/AOT.932994

Ann Transplant 2021; 26:e932994

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Graft survival rates in patients with IMDs and BA. IMDs – inherited metabolic disease, BA – biliary atresia.

Back to the Article

Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases

Your Privacy